Showing results (151-160 of 611) with videos related to
Sort By:
Pageof 62
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 6, 1999
[Influence of nitric oxide synthetase inhibitor on the blood pressure action of clonidine in rats]Y Yatomi, S Hara, M Fukuzawa, et al.Urology|August 5, 2000
Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer modelH Miyake, I Hara, S Hara, et al.The Journal of Biological Chemistry|October 20, 1995
Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response elementH Inoue, C Yokoyama, S Hara, et al.Agricultural and Biological Chemistry|February 1, 1990
Construction of shuttle vector plasmid between Clostridium acetobutylicum and Escherichia coliS Yoshino, T Yoshino, S Hara, et al.Agricultural and Biological Chemistry|June 1, 1990
Chromosomal transformation in Saccharomyces cerevisiae with DNA isolated by pulse field gel electrophoresisK Goto, T Motoyoshi, G Tamura, et al.Pharmacology, Biochemistry, and Behavior|July 1, 1994
Effect of opioid peptide antisera on nitrous oxide antinociception in ratsS Hara, M J Gagnon, R M Quock, et al.Clinical Immunology and Immunopathology|December 1, 1990
The effects of a new immunosuppressive agent, FK506, on the glomerular injury in rats with accelerated nephrotoxic serum glomerulonephritisS Hara, A Fukatsu, N Suzuki, et al.Journal of Biochemistry|June 1, 1987
Conversion of peanut trypsin-chymotrypsin inhibitor B-III to a chymotrypsin inhibitor by deimination of the P1 arginine residues in two reactive sitesT Kurokawa, S Hara, H Takahara, et al.Experimental Eye Research|August 1, 1986
Acidic lens-protein-degrading activity in aqueous humourS Hayasaka, T Fukuyo, S Hara, et al.Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1985
[Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer]H Fuse, K Ando, S Hara, et al.Pageof 62